Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-07-29
Summary
This experiment is designed to analyze the metabolites in body fluids from patients with active tuberculosis and latent tuberculosis infection also with health volunteer, then combine the metabolic product features with clinical characteristics, to develop a kind of metabolites targets to evaluate the progress in tuberculosis, thus provide a basis for further utilization of humoral metabolites in the diagnosis of tuberculosis.
Conditions
- Tuberculosis
- Diagnosis
Interventions
- OTHER
-
with no intervention, Collect samples
only with observation,there is no need to intervene
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Principal Investigators
-
Pintong Huang · Second Affiliated Hospital, School of Medicine, Zhejiang University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2022-10-01
- Completion
- 2022-10-01
Countries
- China
Study Locations
More Related Trials
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735 ·Status: RECRUITING
-
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
NCT04700579 ·Status: RECRUITING
-
Serum Inflammatory Marker in Patients With Diagnosis of Nontuberculous Mycobacterial Pulmonary Infection
NCT00942916 ·Status: COMPLETED
-
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
NCT04074369 ·Status: UNKNOWN
-
Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis
NCT04995406 ·Status: COMPLETED
-
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT06439810 ·Status: RECRUITING
-
Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB
NCT02619240 ·Status: COMPLETED
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
NCT06526689 ·Status: RECRUITING
-
Sputum-free Diagnostis of TB
NCT07125274 ·Status: RECRUITING
-
MDR-TB Close Contacts Tracing in China (TCCT Study)
NCT04484129 ·Status: UNKNOWN
-
A Study of Pattern of Presentation of Pulmonary Tuberculosis Patients Undergoing Treatment at Assiut University Hospital
NCT04055441 ·Status: UNKNOWN
-
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
NCT06021041 ·Status: UNKNOWN
-
Plasma MTB cfDNA Before Bronchoscopy
NCT07230457 ·Status: NOT_YET_RECRUITING
-
Diagnosing of Acute Tuberculosis
NCT03667742 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Treatment of Latent Tuberculosis Infection With Isoniazid
NCT00293228 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
NCT06875336 ·Status: RECRUITING
-
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930 ·Status: ENROLLING_BY_INVITATION
-
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
NCT05477966 ·Status: UNKNOWN
-
Research on New Regimens for Retreatment Pulmonary Tuberculosis
NCT02331823 ·Status: UNKNOWN ·Phase: PHASE4
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinic-based Versus Hotspot-focused Active TB Case Finding
NCT05285202 ·Status: RECRUITING ·Phase: NA